跳至主要内容
临床试验/JPRN-UMIN000014544
JPRN-UMIN000014544招募中1 期

Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2 - Phase I/II study of Carboplatin plus Nab-Paclitaxel in patients with advanced non-small-cell lung cancer and a performance status of 2

Shizuoka cancer center0 个研究点目标入组 33 人开始时间: 2014年7月14日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
入组人数
33

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Symptomatic brain metastasis 2) Interstitial pneumonia with usual interstitial pneumonia pattern on chest CT 3) Grade 2 or more peripheral sense neuropathy 4) With uncontrolled pleural effusion, ascites or pericardial effusion 5) Treated with palliative radiotherapy within the past two weeks 6) Active concomitant malignancy 7) Severe complication 8) HBs antigen positive 9) Previous severe drug allergy 10) Continuous systemic administration of steroid

研究者

相似试验

Phase I/II study of Carboplatin plus Nab-Paclitaxel... | 临床试验